- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05709613
Use of a Feedback Device to Limit Too Shallow Compressions Associated With the Use of an I-gel® Device
September 15, 2023 updated by: Stuby Loric, Geneve TEAM Ambulances
Use of a Feedback Device to Limit Too Shallow Compressions Associated With the Use of an I-gel® Device During Simulated Out-of-Hospital Cardiac Arrest: Simulation-based Multicentre Randomised Controlled Trial
Airway management in out-of-hospital cardiac arrest is still debated.
Several options exist: bag-valve-mask ventilation, supraglottic devices and endotracheal intubation.
Intermediate and advanced airway management strategies could be useful devices to increase chest compression fraction.
A previous study shows that early insertion of an i-gel device significantly increases chest compression fraction and enhances respiratory parameters.
However, the compressions were found to be shallower in the experimental group using the i-gel device.
Although, the shallower compressions found in the supraglottic airway device group did not appear to be linked to their provision in an over-the-head position, it is reasonable to assume that the addition of a feedback device to the use of an i-gel® device could fix this issue.
The feedback devices seem to be able to provide a benefit, and allow deeper compressions / more often in the depth target.
There is a mismatch between perceived and actual cardiopulmonary resuscitation performance supporting the need for such a feedback device's study.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Geneva, Switzerland, 1201
- Genève TEAM Ambulances
-
Geneva, Switzerland, 1211
- SK Ambulances
-
-
Geneva
-
Chêne-Bougeries, Geneva, Switzerland, 1224
- ACE Genève Ambulances
-
-
Valais
-
Sion, Valais, Switzerland, 1950
- Ambulances de la Ville de Sion
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Registered EMTs and paramedics actively working in any of the participating study trial centers will be eligible for inclusion.
Exclusion Criteria:
- Members of the study team
- EMTs will be randomly excluded if there are more EMTs than paramedics.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: No feedback device
This group will have no access to the feedback device
|
|
Experimental: Feedback device
This group will have access to the feedback device
|
The participants will have access to a chest compressions' feedback device
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compressions within the depth target
Time Frame: Through study completion, i.e.10 minutes of scenario.
|
Proportions of compressions within the depth target of 5 to 6 centimeters
|
Through study completion, i.e.10 minutes of scenario.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall chest compression fraction
Time Frame: Through study completion, i.e.10 minutes of scenario.
|
The chest compression fraction is the time during which compressions are provided divided by the total time of the resuscitation
|
Through study completion, i.e.10 minutes of scenario.
|
Depth of chest compressions
Time Frame: Through study completion, i.e.10 minutes of scenario.
|
The depth of chest compressions measured in centimeters
|
Through study completion, i.e.10 minutes of scenario.
|
Compressions within the rate target
Time Frame: Through study completion, i.e.10 minutes of scenario.
|
Proportions of compressions within the rate target of 100 to 120 compressions per minute
|
Through study completion, i.e.10 minutes of scenario.
|
Rate of chest compressions
Time Frame: Through study completion, i.e.10 minutes of scenario.
|
The rate of chest compressions measured in compressions per minute
|
Through study completion, i.e.10 minutes of scenario.
|
Compressions with correct chest recoil
Time Frame: Through study completion, i.e.10 minutes of scenario.
|
The proportions of compressions with complete chest recoil (less than 5 millimeters of deviation from the reference value)
|
Through study completion, i.e.10 minutes of scenario.
|
Time to first effective ventilation
Time Frame: Through study completion, i.e.10 minutes of scenario.
|
The time measured in seconds from beginning of the resuscitation to first effective ventilation (defined as at least 300 millilitres)
|
Through study completion, i.e.10 minutes of scenario.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Loric Stuby, Genève TEAM Ambulances
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 30, 2023
Primary Completion (Actual)
June 13, 2023
Study Completion (Actual)
June 13, 2023
Study Registration Dates
First Submitted
January 8, 2023
First Submitted That Met QC Criteria
February 1, 2023
First Posted (Actual)
February 2, 2023
Study Record Updates
Last Update Posted (Actual)
September 18, 2023
Last Update Submitted That Met QC Criteria
September 15, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CPR-7
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Data from the study will be available on Yareta as soon as the results are submitted for publication.
IPD Sharing Time Frame
Once the final results will be submitted for publication
IPD Sharing Access Criteria
Free access
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Emergency Medicine
-
Samsung Medical CenterRecruitingEmergency Medicine | Medical Informatics | Pediatric Emergency MedicineKorea, Republic of
-
RWTH Aachen UniversityCompletedTelemedicine | Disaster Medicine | Emergency MedicineGermany
-
Washington University School of MedicineEpharmix, Inc.CompletedEmergency Medicine | Mobile Health | General MedicineUnited States
-
Mario Negri Institute for Pharmacological ResearchCentre Hospitalier Universitaire Vaudois; Fondazione Bruno Kessler; Astir S.r.l. and other collaboratorsNot yet recruiting
-
Guangdong Provincial People's HospitalRecruiting
-
Massachusetts General HospitalTerminatedEmergency MedicineUnited States
-
Ataturk UniversityCompletedEmergency MedicineTurkey
-
Mario Negri Institute for Pharmacological ResearchFondazione Bruno Kessler; Astir S.r.l.; Orobix Life S.r.l.Not yet recruiting
-
University of AarhusAarhus University Hospital; Herning Hospital; Horsens Hospital; Randers Regional... and other collaboratorsCompleted
Clinical Trials on Use of a chest compressions' feedback device
-
Pavia nel CuoreRobbio nel CuoreCompletedQuality of Cardio-pulmonary ResuscitationItaly, Switzerland
-
Children's Hospital of PhiladelphiaCompleted
-
Beaumont HospitalCompleted
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedSelf-management for Mobility Improvement in the ElderlyNetherlands
-
University Hospital, CaenRecruitingCardiac Arrest | Cardiopulmonary ResuscitationFrance
-
Sunnaas Rehabilitation HospitalMade for MovementCompleted
-
St. Justine's HospitalFonds de la Recherche en Santé du Québec; Dymedso Inc.; Réseau de Recherche en...UnknownCOVID-19 | Physiotherapy
-
Centre Hospitalier Universitaire de NiceCompleted- Mild and Moderate Presbycusis (20 to 50 dB Average Hearing Loss at 500, 1000, 2000 Hz and 4000 Hz)France
-
Region Örebro CountyÖrebro kommun; Kumla kommunWithdrawnUrinary Incontinence | Urinary Tract Infections | Cognition Disorders in Old Age | Incontinence-associated Dermatitis | Behavioral and Psychiatric Symptoms of DementiaSweden
-
Children's Hospital of PhiladelphiaLaerdal MedicalCompleted